VOYA Investment Management
BCLI

VOYA Investment Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

VOYA Investment Management’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-870
Closed -$50K – 2812
2021
Q1 		$50K Hold
870
– – ﹤0.01% 2744
2020
Q4 		$59K Buy
+870
New +$118K ﹤0.01% 2640

Other funds holding BCLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VOYA Investment Management's BCLI Position: Q2 2021 in Review

VOYA Investment Management sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q2 2021, closing a stake of 870 shares — an estimated $50K sold.

VOYA Investment Management first reported a position in BCLI in Q4 2020 and held it in 2 quarters. The position peaked at $59K in Q4 2020. 57 funds tracked by Wall St. Rank hold BCLI as of Q2 2021.

  • VOYA Investment Management reported no remaining BRAINSTORM CELL THERAPUTC position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 870 BRAINSTORM CELL THERAPUTC shares in Q2 2021, an estimated $50K.
  • VOYA Investment Management first reported a position in BRAINSTORM CELL THERAPUTC in Q4 2020 and held it in 2 quarters.
  • VOYA Investment Management's BRAINSTORM CELL THERAPUTC position peaked at $59K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.